Clinical Trial Update: Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing a four-drug combination (gemcitabine, cisplatin, AB680, AB122) as first-line therapy for advanced biliary tract cancers is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Drugs mentioned

• AB122
• AB680
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Nataliya Uboha | Conditions: Biliary Tract Carcinoma, Cholangiocarcinoma | Phase 2 | Status: RECRUITING